drugset

drugset / Trial / NCT00132600

Clinical Evaluation of Bacitracin

NCT00132600 ↗

Phase 2 Completed 20 enrolled Mekos Laboratories AS

Non-randomizedSingle-groupDouble-blindDiagnostic

Summary

The purpose of this study is to establish a concentration of a bacitracin-patch for diagnosing allergic contact dermatitis.

Timeline

Start: 2005-04
Primary completion: —
Completion: 2005-07

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Bacitracin	Unknown	—	—

Indications